Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Involvement of poly (ADP-Ribose)-polymerase in the Pax-6 gene regulation in neuroretina

Abstract

The quail Pax-6 gene is expressed from two promoters named P0 and P1. P0 promoter is under the control of a neuroretina-specific enhancer (EP). This enhancer activates the P0 promoter specifically in neuroretina cells and in a developmental stage-dependent manner. The EP enhancer binds efficiently, as revealed by southwestern experiments, to a 110 kDa protein present in neuroretina cells but not in Quail Embryos Cells and Retinal Pigmented Epithelium which do not express the P0-initiated mRNAs. To study the role of p110 in Pax-6 regulation, we have purified the p110 from neuroretina cells extracts. Based on the peptide sequence of the purified protein, we have identified the p110 as the poly(ADP-ribose) polymerase (PARP). Using bandshift experiments and footprinting studies, we present evidence that PARP is a component of protein complexes bound to the EP enhancer that increases the on rate of the protein complex formation to DNA. Using PARP inhibitors (3AB and 6.5 Hphe), we show that these products are able to inhibit EP enhancer activity in neuroretina cells. Finally, we demonstrate that these inhibitors are able to decrease the expression of the P0-initiated mRNA in the MC29-infected RPE cells which, in contrast to the RPE cells, accumulated the PARP in response to v-myc expression. Our results suggest that PARP is involved in the Pax-6 regulation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Barbu V and Dautry F. . 1989 Nucl. Acids Res. 17: 7115.

  • Berger NA. . 1985 Radiat. Res. 101: 4–15.

  • Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF and Koonin EV. . 1997 FASEB J. 11: 68–76.

  • Bruhn L, Munnerlyn A and Grosschedl R. . 1997 Genes & Dev. 11: 640–653.

  • Callaerts P, Halder G and Gehring W. . 1997 Annu. Rev. Neurosci. 20: 483–532.

  • Callebaut I and Mornon JP. . 1997 LETTS Letts. 400: 25–30.

  • Carrière C, Plaza S, Martin P, Quatannens B, Stéhelin D and Saule S. . 1993 Mol. Cell. Biol. 13: 7257–7266.

  • Chatterjee S and Berger NA. . 1994 Mol. Cell. Biochem. 138: 61–69.

  • Chomczynski P and Sacchi N. . 1987 Anal. Biochem. 162: 156–159.

  • Dahl E, Koseki H and Balling R. . 1997 BioEssays 19: 755–765.

  • Davis RJ, D'Cruz CM, Lovell MA, Biegel JA and Barr FG. . 1994 Cancer Res. 54: 2869–2872.

  • Dear TN, Hainzl T, Follo M, Nehls M, Wilmore H, Matena K and Boehm T. . 1997 Oncogene 14: 891–898.

  • Ding R and Smulson ME. . 1994 Cancer Res. 54: 4627–4634.

  • Dozier C, Carriere C, Grevin D, Martin P, Quatannens B, Stéhelin D and Saule S. . 1993 Cell Growth and Differ. 4: 281–289.

  • Fujiwara M, Uchida T, Osumi-Yamashita N and Eto K. . 1994 Differentiation 57: 31–38.

  • Gaillard C and Stauss F. . 1994 Science 264: 433–436.

  • Galili N, Davis RJ, Fredericks WJ, Mukhopadhyav S, Rauscher FJ III, Emanuel BS, Rovera G and Barr FG. . 1993 Nature Genet. 5: 230–235.

  • Glardon S, Callaerts P, Halder G and Gehring WJ. . 1997 Development 124: 817–825.

  • Halder G, Callaerts P and Gehring WJ. . 1995 Science 267: 1788–1792.

  • Hill RE, Favor J, Hogan B, Ton CC, Saunders G, Hanson I, Prosser J, Jordan T, Hastie N and Heyningen VV. . 1991 Nature 354: 522–525.

  • Ittel ME, Garnier JM, Jeltsch JM and Niedergang CP. . 1991 Gene 102: 157–164.

  • Larson CJ and Verdine GL. . 1992 Nucl. Acids Res. 20: 3525.

  • Lindahl T, Satoh MS, Poirier GG and Klungland A. . 1995 Trends Biochem. Sci. 20: 405–411.

  • Malanga M, Pleschke JM, Kleczkowska HE and Althaus FR. . 1998 J. Biol. Chem. 273: 11839–11843.

  • Mansouri A, Hallonet M and Gruss P. . 1996 Curr. Opin. Cell Biol. 8: 951–957.

  • Maulbecker CC and Gruss P. . 1993 EMBO J. 12: 2361–2367.

  • Meisterernst M, Stelzer G and Roeder RG. . 1997 Proc. Natl. Acad. Sci. 94: 2261–2265.

  • Moncollin V, Stalder R, Verdier JM, Sentenac A and Egly JM. . 1990 Nucl. Acids Res. 18: 4817–4823.

  • de Murcia G, Menissier-de Murcia JM and Schreiber V. . 1991 BioEssays 13: 455–462.

  • de Murcia G and Menissier-de Murcia JM. . 1994 Trends Biochem. Sci. 19: 172–176.

  • Nesterenko MV, Tilley M and Upton SJ. . 1994 J. Biochem. Biophys. Methods 28: 239–242.

  • Nie J, Sakamoto S, Song D, Qu Z, Ota K and Taniguchi T. . 1998 FEBS Lett. 424: 27–32.

  • Oei SL, Griesenbeck J and Schweiger M. . 1997 Rev. Physiol. Biochem. Pharmacol. 131: 127–173.

  • Oei SL, Griesenbeck J, Schweiger M, Babich V, Kropotov A and Tomilin N. . 1997 Biochem. Biophys. Res. Comm. 240: 108–111.

  • Plaza S, Dozier C and Saule S. . 1993 Cell Growth and Differ. 4: 1041–1050.

  • Plaza S, Dozier C, Langlois MC and Saule S. . 1995a Mol. Cell. Biol. 15: 892–903.

  • Plaza S, Dozier C, Turque N and Saule S. . 1995b Mol. Cell. Biol. 15: 3344–3353.

  • Prosser J and Heyningen VV. . 1998 Human Mutations 11: 93–108.

  • Quiring R, Walldorf U, Kloter U and Gehring WJ. . 1994 Science 265: 785–789.

  • Sastry ? and Kun E. . 1990 Biochem. Biophys. Res. Comm. 167: 842–847.

  • Simbulan-Rosenthal CM, Rosenthal DS, Hilz H, Hickey R, Malkas L, Applegren N, Wu Y, Bers G and Smulson ME. . 1996 Biochemistry 35: 11622–11633.

  • Smulson ME, Istock N, Ding R and Cherney B. . 1994 Biochemistry 33: 6186–6191.

  • Stevnsner T, Ding R, Smulson ME and Bohr VA. . 1994 Nucl. Acid Res. 22: 4620–4624.

  • Tewari M, Quan LT, O'Rourke K, Desnoyer S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM. . 1995 Cell 81: 801–809.

  • Tomarev SI, Callaerts P, Kos L, Zinovieva R, Halder G, Gehring W and Piatigorsky J. . 1997 Proc. Natl. Acad. Sci. 94: 2421–2426.

  • Turque N, Plaza S, Radvanyi F, Carrière C and Saule S. . 1994 Mol. Endocrinol. 8: 929–938.

  • Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG and Benchimol S. . 1997 EMBO J. 16: 6018–6033.

  • Weltin D, Holl V, Hyun JW, Dufour P, Marchal J and Bischoff P. . 1997 Int. J. Radiat. Biol. 72: 685–692.

  • Wesierska J, Schimd G and Cerni C. . 1996 Biochem. Biophys. Res. Comm. 224: 96–102.

Download references

Acknowledgements

This work was supported by grants from the Centre National de la Recherche Scientifique, Institut Pasteur de Lille, Association de Recherche contre le Cancer, la Ligue nationale contre le cancer, and the Association Française Retinitis Pigmentosa. We acknowledge T Taniguchi for the gift of His tagged PARS/AMD vector, G. Poirier and G. de Murcia for the PARP antibodies and G. de Murcia for the pECV PARP expression vector. We acknowledge K. Opdecamp for critical reading of the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plaza, S., Aumercier, M., Bailly, M. et al. Involvement of poly (ADP-Ribose)-polymerase in the Pax-6 gene regulation in neuroretina. Oncogene 18, 1041–1051 (1999). https://doi.org/10.1038/sj.onc.1202406

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202406

Keywords

This article is cited by

Search

Quick links